336 related articles for article (PubMed ID: 25143337)
1. Serum concentrations of interleukin-2 and tumour necrosis factor-α under cyclosporine versus acitretin treatment in plaque-type psoriasis.
Akçali C; Guven EH; Kirtak N; Inaloz HS; Ozgoztasi O; Guvenc U
J Int Med Res; 2014 Oct; 42(5):1118-22. PubMed ID: 25143337
[TBL] [Abstract][Full Text] [Related]
2. Changes in serum TNF-like weak inducer of apoptosis (TWEAK) levels and Psoriasis Area Severity Index (PASI) scores in plaque psoriasis patients treated with conventional versus anti-TNF treatments.
Engin B; Tanakol A; Bulut H; Songür A; Vehid HE; Gökalp E; Kutlubay Z; Özkoca D; Tüzün Y; Serdaroğlu S
Int J Dermatol; 2020 Feb; 59(2):207-215. PubMed ID: 31531981
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of acitretin in three fixed doses of 25, 35 and 50 mg in adult patients with severe plaque type psoriasis: a randomized, double blind, parallel group, dose ranging study.
Dogra S; Jain A; Kanwar AJ
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e305-11. PubMed ID: 22816881
[TBL] [Abstract][Full Text] [Related]
4. Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis.
Mussi A; Bonifati C; Carducci M; D'Agosto G; Pimpinelli F; D'Urso D; D'Auria L; Fazio M; Ameglio F
J Biol Regul Homeost Agents; 1997; 11(3):115-8. PubMed ID: 9498161
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial.
Caproni M; Antiga E; Melani L; Volpi W; Del Bianco E; Fabbri P
J Clin Immunol; 2009 Mar; 29(2):210-4. PubMed ID: 18763027
[TBL] [Abstract][Full Text] [Related]
6. Secukinumab (Cosentyx°) and plaque psoriasis.
Prescrire Int; 2017 Mar; 26(180):61-62. PubMed ID: 30730616
[No Abstract] [Full Text] [Related]
7. HLA-G 14-bp polymorphism: a possible marker of systemic treatment response in psoriasis vulgaris? Preliminary results of a retrospective study.
Borghi A; Rizzo R; Corazza M; Bertoldi AM; Bortolotti D; Sturabotti G; Virgili A; Di Luca D
Dermatol Ther; 2014; 27(5):284-9. PubMed ID: 24909182
[TBL] [Abstract][Full Text] [Related]
8. Erythroderma in a patient taking acitretin for plaque psoriasis.
Ahdout J; Mandel H; Chiu M
J Drugs Dermatol; 2008 Apr; 7(4):391-4. PubMed ID: 18459522
[TBL] [Abstract][Full Text] [Related]
9. Algorithm to select optimal systemic anti-psoriatic drugs in relation with patients' Psoriasis Area and Severity Index score for plaque psoriasis.
Bae SH; Yun SJ; Lee JB; Kim SJ; Won YH; Lee SC
J Dermatol; 2016 Jun; 43(6):643-9. PubMed ID: 26598783
[TBL] [Abstract][Full Text] [Related]
10. Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis.
Kuijpers AL; van Dooren-Greebe JV; van de Kerkhof PC
Dermatology; 1997; 194(1):88-90. PubMed ID: 9031805
[No Abstract] [Full Text] [Related]
11. The role of etanercept on the expression of markers of T helper 17 cells and their precursors in skin lesions of patients with psoriasis vulgaris.
Antiga E; Volpi W; Chiarini C; Cardilicchia E; Filì L; Manuelli C; Parrochi P; Fabbri P; Caproni M
Int J Immunopathol Pharmacol; 2010; 23(3):767-74. PubMed ID: 20943046
[TBL] [Abstract][Full Text] [Related]
12. Lowering Interleukin-12 Activity Improves Myocardial and Vascular Function Compared With Tumor Necrosis Factor-a Antagonism or Cyclosporine in Psoriasis.
Ikonomidis I; Papadavid E; Makavos G; Andreadou I; Varoudi M; Gravanis K; Theodoropoulos K; Pavlidis G; Triantafyllidi H; Moutsatsou P; Panagiotou C; Parissis J; Iliodromitis E; Lekakis J; Rigopoulos D
Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28899951
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of acitretin and commercial tanning bed therapy for psoriasis.
Carlin CS; Callis KP; Krueger GG
Arch Dermatol; 2003 Apr; 139(4):436-42. PubMed ID: 12707089
[TBL] [Abstract][Full Text] [Related]
14. A global approach to psoriatic patients through PASI score and Skindex-29.
Prignano F; Ruffo G; Ricceri F; Pescitelli L; Lotti T
G Ital Dermatol Venereol; 2011 Feb; 146(1):47-52. PubMed ID: 21317856
[TBL] [Abstract][Full Text] [Related]
15. Curcumin nanoparticles potentiate therapeutic effectiveness of acitrein in moderate-to-severe psoriasis patients and control serum cholesterol levels.
Bilia AR; Bergonzi MC; Isacchi B; Antiga E; Caproni M
J Pharm Pharmacol; 2018 Jul; 70(7):919-928. PubMed ID: 29600580
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study.
Janagond AB; Kanwar AJ; Handa S
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e384-9. PubMed ID: 23066720
[TBL] [Abstract][Full Text] [Related]
17. Sequential therapy using cyclosporine and acitretin for treatment of total body psoriasis.
Short MW; Vaughan TK
Cutis; 2004 Sep; 74(3):185-8. PubMed ID: 15499760
[TBL] [Abstract][Full Text] [Related]
18. A randomized comparison of acitretin-narrow-band TL-01 phototherapy and acitretin-psoralen plus ultraviolet A for psoriasis.
Ozdemir M; Engin B; Baysal I; Mevlitoğlu I
Acta Derm Venereol; 2008; 88(6):589-93. PubMed ID: 19002344
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of total glucosides of paeony combined with acitretin in the treatment of moderate-to-severe plaque psoriasis: a double-blind, randomised, placebo-controlled trial.
Yu C; Fan X; Li Z; Liu X; Wang G
Eur J Dermatol; 2017 Apr; 27(2):150-154. PubMed ID: 28400341
[TBL] [Abstract][Full Text] [Related]
20. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
Gisondi P; Del Giglio M; Cotena C; Girolomoni G
Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]